How has nanomedical innovation contributed to the COVID-19 vaccine development?

Figueiró Longo, João Paulo; Muehlmann, Luis Alexandre

Figueiró Longo, João Paulo; Muehlmann, Luis Alexandre.

Figueiró Longo JP; Institute of Biological Sciences, University of Brasília, Brasília DF 70910 900, Brazil.
Muehlmann LA; Faculty of Ceilândia, University of Brasília, Brasília DF 72220 900, Brazil.

Nanomedicine (Lond) ; 16(14): 1179-1181, 2021 06.

Article in English | MEDLINE | ID: covidwho-1223837

Subject(s)

COVID-19 Vaccines; COVID-19; Nanomedicine/trends; Nanotechnology/trends; Humans; Inventions

Keywords

COVID-19; innovation; lipid nanoparticles; nanomedicine; nanotechnology; vaccine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Nanotechnology / Nanomedicine / COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Nanomedicine (Lond) Year: 2021 Document Type: Article Affiliation country: Nnm-2021-0035

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google